Home › Head and Neck Cancer › Illinois
Head and Neck Cancer clinical trials in Illinois
10 studies for Head and Neck Cancer are looking for participants at sites in Illinois.
Cities in Illinois
DESTINY-PANTUMOUR04
- Research Site, Decatur
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- University of Illinois Cancer Center, Chicago
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06172478A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment
- The University of Chicago, Chicago
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 16, 2026 · NCT07179315A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- University of Chicago, Chicago
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
- University of Chicago Comprehensive Cancer Center, Chicago
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 12, 2026 · NCT05420948Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
- The University of Chicago, Chicago
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Mar 4, 2026 · NCT05526924Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer
- The University of Chicago, Chicago
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 4, 2026 · NCT07065630Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Dec 2, 2025 · NCT06912087SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chicago
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer
- University of Illinois at Chicago, Chicago
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 17, 2025 · NCT05838729From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.